Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hanns Ulrich Zeilhofer

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Reviews of Physiology, Biochemistry and Pharmacology|August 2, 2005
Synaptic modulation in pain pathwaysHanns Ulrich Zeilhofer
International Immunopharmacology|January 10, 2008
Loss of glycinergic and GABAergic inhibition in chronic pain--contributions of inflammation and microgliaHanns Ulrich Zeilhofer
Biochemical Pharmacology|September 9, 2006
Prostanoids in nociception and painHanns Ulrich Zeilhofer
The Journal of Pharmacology and Experimental Therapeutics|May 2, 2003
Nociceptin/orphanin FQ and its receptor--potential targets for pain therapy?Hanns Ulrich Zeilhofer, Girolamo Calò
Trends in Pharmacological Sciences|August 1, 2006
Analgesic strategies beyond the inhibition of cyclooxygenasesHanns Ulrich Zeilhofer, Kay Brune
Plos One|September 9, 2011
Molecular sites for the positive allosteric modulation of glycine receptors by endocannabinoidsGonzalo E Yévenes, Hanns Ulrich Zeilhofer
British Journal of Pharmacology|May 12, 2011
Allosteric modulation of glycine receptorsGonzalo E Yevenes, Hanns Ulrich Zeilhofer
Neuroscience Letters|April 15, 2008
Spinal dis-inhibition in inflammatory painHanns Ulrich Zeilhofer, Ulrike B Zeilhofer
Neuropharmacology|March 5, 2004
Gabapentin may inhibit synaptic transmission in the mouse spinal cord dorsal horn through a preferential block of P/Q-type Ca2+ channelsKatharina Bayer, Seifollah Ahmadi, Hanns Ulrich Zeilhofer
Pain|August 11, 2020
The α2/α3GABAA receptor modulator TPA023B alleviates not only the sensory but also the tonic affective component of chronic pain in miceElena Neumann, Laura Küpfer, Hanns Ulrich Zeilhofer
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Reviews of Physiology, Biochemistry and Pharmacology|August 2, 2005
Synaptic modulation in pain pathwaysHanns Ulrich Zeilhofer
International Immunopharmacology|January 10, 2008
Loss of glycinergic and GABAergic inhibition in chronic pain--contributions of inflammation and microgliaHanns Ulrich Zeilhofer
Biochemical Pharmacology|September 9, 2006
Prostanoids in nociception and painHanns Ulrich Zeilhofer
The Journal of Pharmacology and Experimental Therapeutics|May 2, 2003
Nociceptin/orphanin FQ and its receptor--potential targets for pain therapy?Hanns Ulrich Zeilhofer, Girolamo Calò
Trends in Pharmacological Sciences|August 1, 2006
Analgesic strategies beyond the inhibition of cyclooxygenasesHanns Ulrich Zeilhofer, Kay Brune
Plos One|September 9, 2011
Molecular sites for the positive allosteric modulation of glycine receptors by endocannabinoidsGonzalo E Yévenes, Hanns Ulrich Zeilhofer
British Journal of Pharmacology|May 12, 2011
Allosteric modulation of glycine receptorsGonzalo E Yevenes, Hanns Ulrich Zeilhofer
Neuroscience Letters|April 15, 2008
Spinal dis-inhibition in inflammatory painHanns Ulrich Zeilhofer, Ulrike B Zeilhofer
Neuropharmacology|March 5, 2004
Gabapentin may inhibit synaptic transmission in the mouse spinal cord dorsal horn through a preferential block of P/Q-type Ca2+ channelsKatharina Bayer, Seifollah Ahmadi, Hanns Ulrich Zeilhofer
Pain|August 11, 2020
The α2/α3GABAA receptor modulator TPA023B alleviates not only the sensory but also the tonic affective component of chronic pain in miceElena Neumann, Laura Küpfer, Hanns Ulrich Zeilhofer
Pageof 13